This article is more than 5 years old. Information may no longer be current.

Iridex’s Cyclo G6 glaucoma laser approved in South Korea

Issue: June 2018

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

South Korea’s Ministry of Food and Drug Safety has approved the Cyclo G6 glaucoma laser system, Iridex announced in a press release.

The Cyclo G6 is available in more than 50 countries to treat patients with a range of glaucoma disease, the release said. It uses Iridex’s MicroPulse technology.

“International expansion in the Asia-Pacific region remains a top priority for us, and we believe that Korea represents an attractive market for our G6 technology,” President and CEO of Iridex William M. Moore said in the release.